Recruiting

4

100

RoW

Tenofovir Alafenamide 25 MG, Vemlidy

New Discovery LLC, Beijing Ditan Hospital

Hepatitis B, Chronic

09/23

09/23

Recruiting

4

32000

RoW

Amlodipine besylate, Amlodipine, Amlodipine besylate and folic acid, Amlodipine folic acid, Anye, Amlodipine placebos, Amlodipine (dummy), Amlodipine-folic acid placebos, Amlodipine-folic acid (dummy)

Shenzhen Ausa Pharmed Co.,Ltd, Peking University First Hospital, Second Affiliated Hospital of Nanchang University, The First People's Hospital of Lianyungang, The Affiliated Hospital Of Guizhou Medical University, Lianyungang Oriental Hospital, Tengzhou Central People's Hospital, First Affiliated Hospital Bengbu Medical College, H & J CRO International, Inc., Shenzhen Prospective Medical Technology Co., LTD

Hypertension, MTHFR 677 CC or CT Genotype, Elevated Plasma Homocysteine (Hcy≥10µmol/L), Insufficient Plasma Folate Levels (<12ng/mL)

06/29

06/29

Recruiting

3

392

RoW

TQB2450 Injection, Anlotinib hydrochloride, Oxaliplatin injection, Capecitabine tablets, Gemcitabine hydrochloride injection

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Advanced Biliary Cancer

03/22

02/23

Recruiting

3

312

RoW

Icaritin, SNG-162, HUACHANSU PIAN, HUACHANSU PIAN（999）

Beijing Shenogen Biomedical Co., Ltd, Chinese Academy of Medical Sciences, NanJing PLA 81 Hospital, Peking University Cancer Hospital & Institute, Beijing Hospital, Guang'anmen Hospital of China Academy of Chinese Medical Sciences, Jinan Central Hospital, Linyi Tumour Hospital, The First Affiliated Hospital of Anhui Medical University, Anhui Provincial Hospital, The First Affiliated Hospital with Nanjing Medical University, The Affiliated Tumor Hospital of Nantong University, Nantong, Jiangsu Province, China, Nanfang Hospital of Southern Medical University, First People's Hospital of Foshan, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Hebei Medical University Fourth Hospital, The First Hospital of Jilin University, Haikou People's Hospital, Fudan University, West China Hospital, Chongqing Traditional Chinese Medicine Hospital, Chifeng Municipal Hospital, The Affiliated Hospital of Hangzhou Normal University, The First Affiliated Hospital of Zhengzhou University, Guilin Medical University, China, The Third Xiangya Hospital of Central South University, Yunnan Provincial Hospital of Traditional Chinese Medicine, The Sixth People's Hospital of Shenyang

Advanced HBV-Related Hepatocellular Carcinoma (HCC)

12/22

12/22

Recruiting

3

282

RoW

Catumaxomab, The treatment of investigator choice

LintonPharm Co.,Ltd.

Stomach Neoplasms

03/23

08/23

Recruiting

3

560

RoW

Irinotecan Hydrochloride Injection, HX008, Placebo

Taizhou Hanzhong biomedical co. LTD

Stomach Cancer

08/23

08/23

Recruiting

3

400

RoW

HB0017 Q4W, HB0017 Q8W, placebo

Huabo Biopharm Co., Ltd.

Psoriasis

08/24

12/25

Active, not recruiting

3

866

Europe, Japan, US, RoW

Imlunestrant, LY3484356, Exemestane, Fulvestrant, Abemaciclib, LY2835219

Eli Lilly and Company, Eli Lilly and Company

Breast Neoplasms, Neoplasm Metastasis

06/24

08/27

Active, not recruiting

3

747

RoW

JS005 (recombinant humanized monoclonal antibody against IL-17A)

Shanghai Junshi Bioscience Co., Ltd.

Moderate to Severe Chronic Plaque Psoriasis

08/25

10/25

Active, not recruiting

3

654

Europe, Canada, Japan, US, RoW

Tucatinib, TUKYSA, ONT-380, ARRY-380, Trastuzumab, Herceptin, Herceptin Hylecta, Pertuzumab, Perjeta, Combination product: Trastuzumab + Pertuzumab, Phesgo, Placebo

Seagen Inc., Merck Sharp & Dohme LLC

HER2 Positive Breast Cancer

05/25

10/27

Active, not recruiting

3

160

Europe, Japan, US, RoW

efgartigimod PH20 SC, Prednisone

argenx, argenx BV

Bullous Pemphigoid

01/26

03/26

Recruiting

3

248

RoW

Hydronidone capsules, F351, The placebo capsules, N

Beijing Continent Pharmaceutical Co, Ltd.

Liver Fibrosis

06/28

10/28

Active, not recruiting

2/3

301

RoW

RC48-ADC, RC48, Lapatinib, Capecitabine

RemeGen Co., Ltd.

Breast Neoplasms, Breast Diseases, Capecitabine, HER2-positive Breast Cancer, HER2 Positive Breast Carcinoma, HER2-positive Advanced Breast With Liver Metastases

07/24

12/24

Recruiting

2/3

132

RoW

B007

Shanghai Jiaolian Drug Research and Development Co., Ltd, Shanghai Pharmaceuticals Holding Co., Ltd

Pemphigus

12/26

12/26

Active, not recruiting

2

57

RoW

RC48-ADC, Recombinant Humanized anti-HER2 Monoclonal Antibody-MMAE Conjugate For Injection

RemeGen Co., Ltd.

Biliary Tract Cancer

11/23

06/24

Recruiting

2

144

RoW

physician's choice of chemotherapy sequential Ribociclib combined with NSAI±OFS, Ribociclib combined with NSAI±OFS

The First Affiliated Hospital with Nanjing Medical University, Zhejiang Cancer Hospital

Advanced Breast Cancer

11/25

12/25

Active, not recruiting

2

103

RoW

Encorafenib, Braftovi®, PF-07263896, W0090, LGX818, ONO-7702, Cetuximab, Erbitux®, C225, FOLFIRI, Folinic acid + Fluorouracil + Irinotecan

Pierre Fabre Medicament, Merck KGaA, Darmstadt, Germany

BRAF V600E, Metastatic Colorectal Cancer

12/23

01/25

Recruiting

2

190

RoW

Ribociclib combined with AI±OFS, physician's choice of chemotherapy sequential Ribociclib combined with AI±OFS

The First Affiliated Hospital with Nanjing Medical University, Yidu Central Hospital of Weifang, Affiliated Hospital of Jiangnan University, The Affiliated Jiangyin Hospital of Southeast University Medical College

Advanced Breast Cancer

12/25

12/25

Withdrawn

2

80

Europe, RoW

YH001 + Toripalimab

Eucure (Beijing) Biopharma Co., Ltd

HCC, NSCLC Stage IIIB, NSCLC Stage IV

12/24

03/25

Recruiting

1/2

280

RoW

SAF-189s, foritinib succinate

Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.

Advanced Cancer, Advanced Solid Tumor, Lung Cancer, Nonsmall Cell

12/22

03/26

Recruiting

1/2

320

RoW

TST001, Oxaliplatin, Capecitabine, Paclitaxel, Gemcitabine, Cisplatin, Nivolumab

Suzhou Transcenta Therapeutics Co., Ltd., Bristol-Myers Squibb

Advanced Cancer

02/25

05/25

Recruiting

1/2

56

RoW

ICP-192

Beijing InnoCare Pharma Tech Co., Ltd.

Solid Tumor

12/24

12/24

Completed

1

42

US

Flavoring Agents, Cooling flavor, Nicotine, Nicotine concentration

Yale University, National Institute on Drug Abuse (NIDA)

Nicotine Use Disorder

06/23

07/23

Recruiting

1

26

RoW

BL-M02D1

Sichuan Baili Pharmaceutical Co., Ltd., SystImmune Inc., Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.

Breast Cancer

12/24

12/24

Recruiting

1

85

US, RoW

ABSK061

Abbisko Therapeutics Co, Ltd

Solid Tumor

04/25

04/25

Not yet recruiting

1

172

RoW

MCLA-129: 1500mg or 2000mg IV Q2W, Befotertinib: 75 mg or 100 mg Po QD

Betta Pharmaceuticals Co., Ltd.

Non-Small Cell Lung Cancer、EGFR Sensitive Mutation

11/28

07/29

Recruiting

N/A

5000

RoW

Heart Auscultation and Echocardiography

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Congenital Heart Disease in Children

12/21

06/23

Recruiting

N/A

286

RoW

Antiarrhythmic drug including Propafenone, Sotalol, Dronedarone and Amiodarone, cryoballoon ablation

Ruijin Hospital

Atrial Fibrillation, Persistent, Arrhythmias, Cardiac

07/25

01/26

Recruiting

N/A

680

RoW

Echocardiography acquisition

First Hospital of China Medical University

Pregnancy

08/23

08/24

Recruiting

N/A

100

RoW

Inetetamab, Pyrotinib, Vinorelbine

The First Affiliated Hospital with Nanjing Medical University

Breast Neoplasms

03/24

03/24

Recruiting

N/A

30

US

E-liquid coolant (WS-3, 0.05%), Flavor type, E-liquid coolant (WS-3, 0.1%), E-liquid coolant (WS-3, 0.5%), E-liquid coolant (WS-3, 1.0%), E-liquid coolant (WS-3, 2.0%), E-liquid coolant (menthol, 0.05%), E-liquid coolant (menthol, 0.1%), E-liquid coolant (menthol, 0.5%), E-liquid coolant (menthol, 1.0%), E-liquid coolant (menthol, 2.0%), E-liquid coolant (WS-23, 0.05%), E-liquid coolant (WS-23, 0.1%), E-liquid coolant (WS-23, 0.5%), E-liquid coolant (WS-23, 1.0%), E-liquid coolant (WS-23, 2.0%), E-liquid coolant (WS-23, 4.0%)

Yale University, National Institute on Drug Abuse (NIDA)

E-Cig Use

01/26

01/26

Recruiting

N/A

366

RoW

Cardiopulmonary rehabilitation, Usual care

The First Affiliated Hospital with Nanjing Medical University

Critical Illness

06/25

12/25

Active, not recruiting

N/A

94

RoW

Tracheal tube-tongue pressure is measured using a computerized occlusal analysis system based on T-Scan® technique, suitable for multi-point real-time monitoring of intraoral pressure.

China-Japan Friendship Hospital

Tracheal Tube-related Tongue Injury

08/24

12/25

Recruiting

N/A

200000

Europe, Canada, RoW

Population Health Research Institute, Canadian Institutes of Health Research (CIHR), Heart and Stroke Foundation of Ontario

Cardiovascular Diseases, Risk Factor, Cardiovascular, Health Behavior, Environmental Exposure, Lung Diseases, Cancer, Injuries, Renal Disease, Communicable Disease

12/30

12/30

Recruiting

N/A

100

RoW

TKIs

The First Affiliated Hospital with Nanjing Medical University

Breast Cancer

12/22

12/22

Recruiting

N/A

100

RoW

stool and blood collection

The First Affiliated Hospital with Nanjing Medical University

Breast Cancer

05/24

06/25

Not yet recruiting

N/A

315

NA

The First Affiliated Hospital with Nanjing Medical University

HER2-negative Breast Cancer

02/25

09/25

Completed

2

250

RoW

GLS4, Morphothiadine Mesilate Capsules, RTV, Ritonavir tablet, ETV, Entecavir table

Sunshine Lake Pharma Co., Ltd.

Chronic HBV Infection

06/22

09/23

Recruiting

N/A

200000

RoW

Beijing Friendship Hospital, Beijing YouAn Hospital, The First Hospital of Jilin University, Henan Provincial People's Hospital, Beijing Ditan Hospital, First Affiliated Hospital of Xinjiang Medical University, LanZhou University, The Second Affiliated Hospital of Chongqing Medical University, West China Hospital, Taiyuan No.3 Hospital, Hebei Medical University Third Hospital, Shengjing Hospital, Tianjin Third Central Hospital, Peking University First Hospital, Peking Union Medical College Hospital, The Affiliated Hospital Of Southwest Medical University, Shanghai Public Health Clinical Center, Ruijin Hospital, First Affiliated Hospital Xi'an Jiaotong University, Xiangya Hospital of Central South University, Beijing Tiantan Hospital, Wuhan University, The First Affiliated Hospital of Kunming Medical College, The Affiliated Hospital of Xuzhou Medical University, The Affiliated Hospital of Yanbian University, First Affiliated Hospital of Chongqing Medical University, The Fouth Hospital of Qinghai province, Weifang Medical University, Hunan Provincial People's Hospital, The Second Hospital of Hebei Medical University, Xixi Hospital of Hangzhou, General Hospital of Ningxia Medical University, Union Hospital,Tong Ji Medical College,Huazhong University of Science and Technology, Xinjiang Uygur Autonomous Region Traditional Chinese Medicine Hospital, Peking University People's Hospital, Nanfang Hospital of Southern Medical University, The Affiliated Hospital Of Guizhou Medical University, Guizhou Provincial People's Hospital, Hainan General Hospital, The Second Hospital of Shandong University, The First Affiliated Hospital of Shanxi Medical University, Fifth Hospital of Shijiazhuang City, Yan'an University Affiliated Hospital, Infectious Disease Hospital of Wuhai, Logistics University of Chinese People's Armed Police Forces, People's Hospital of Changji Hui Autonomous Prefecture，Xinjiang

Chronic Hepatitis B

12/22

12/25

Recruiting

4

120

RoW

Empagliflozin 10 MG, Jardiance®, Placebo

China National Center for Cardiovascular Diseases

Pre-Heart Failure, Hypertension

10/24

12/24

Recruiting

3

12500

Europe, Canada, Japan, US, RoW

Lepodisiran Sodium, LY3819469, Placebo

Eli Lilly and Company

Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a)

03/29

03/29

Active, not recruiting

3

871

Europe, Canada, Japan, US, RoW

Bepirovirsen, Placebo

GlaxoSmithKline, GlaxoSmithKline Research & Development Limited

Chronic Hepatitis B, Hepatitis B, Chronic

11/25

05/26

Recruiting

N/A

5000

RoW

Protocol initiate with A, Protocol initiate with C, Protocol initiate with D

China National Center for Cardiovascular Diseases

Hypertension

03/22

03/22

Recruiting

N/A

100

RoW

mobile internet healthcare and "co-management of three disciplines"

The First Affiliated Hospital of Xiamen University

Overweight/Obesity, Prediabetes, Weight Management

03/25

03/25

Recruiting

N/A

10000

RoW

Psychometric hepatic encephalopathy score & Stroop test, Drug therapy

Hepatopancreatobiliary Surgery Institute of Gansu Province, The First Affiliated Hospital of Anhui Medical University, Beijing Ditan Hospital, Chongqing Public Health Medical Treatment Center, Meng Chao Hepatobiliary Hospital of Fujian Medical University, Guangxi Zhuang Autonomous Region People's Hospital, Shenzhen Third People's Hospital, Guizhou people's Hospital, Wuhan Union Hospital, China, Xiangya Hospital of Central South University, The Second Affiliated Hospital of Hainan Medical University, The Third Affiliated Hospital of Hebei Medical University, The Second Affiliated Hospital of Harbin Medical University, Henan Provincial People's Hospital, Ganzhou Fifth People's Hospital, The First Hospital of Jilin University, Jiangsu People's Hospital, First Hospital of China Medical University, The Second Affiliated Hospital of Baotou Medical College, Ningxia Medical University General Hospital, The Fourth People's Hospital of Qinghai Province, Xi'an High-tech Hospital, The 10th People's Hospital affiliated to Tongji University, Qilu Hospital of Shandong University, The Third People's Hospital of Taiyuan, Xichang People's Hospital, Tianjin Third Central Hospital, The Third People's Hospital of Tibet Autonomous Region, Xinjiang Autonomous Region People's Hospital, Second People's Hospital of Yunnan Province, Hangzhou Xixi hospital, LanZhou University

Hepatic Encephalopathy, Cirrhosis

12/24

12/24